Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c3390
Identifier NCT02130362
Trial Title A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions -
Participant Information
Sponsor AbbVie
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2014-08-28
Primary Completion Date 2030-11
Completion Date 2030-11